Literature DB >> 12732455

Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism.

David F V Lewis1, Elizabeth M J Gillam, Steven A Everett, Tsutomu Shimada.   

Abstract

Molecular modelling of human CYP1B1 based on homology with the mammalian P450, CYP2C5, of known three-dimensional structure is reported. The enzyme model has been used to investigate the likely mode of binding for selected CYP1B1 substrates, particularly with regard to the possible effects of allelic variants of CYP1B1 on metabolism. In general, it appears that the CYP1B1 model is consistent with known substrate selectivity for the enzyme, and the sites of metabolism can be rationalized in terms of specific contacts with key amino acid residues within the CYP1B1 heme locus. Furthermore, a mode of binding interaction for the inhibitor, alpha-naphthoflavone, is presented which accords with currently available information. The current paper shows that a combination of molecular modelling and experimental determinations on the substrate metabolism for CYP1B1 allelic variants can aid in the understanding of structure-function relationships within P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732455     DOI: 10.1016/s0009-2797(03)00021-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

1.  Comparative docking studies of CYP1b1 and its PCG-associated mutant forms.

Authors:  Malkaram Sridhar Achary; Hampapathalu Adimurthy Nagarajam
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

2.  Specificity determinants of CYP1B1 estradiol hydroxylation.

Authors:  Clinton R Nishida; Steven Everett; Paul R Ortiz de Montellano
Journal:  Mol Pharmacol       Date:  2013-07-02       Impact factor: 4.436

3.  Cytochrome P450 1A, 1B, and 1C mRNA induction patterns in three-spined stickleback exposed to a transient and a persistent inducer.

Authors:  Kai Gao; Ingvar Brandt; Jared V Goldstone; Maria E Jönsson
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-02-25       Impact factor: 3.228

4.  Disease-causing mutations in proteins: structural analysis of the CYP1B1 mutations causing primary congenital glaucoma in humans.

Authors:  Malkaram S Achary; Aramati B M Reddy; Subhabrata Chakrabarti; Shirly G Panicker; Anil K Mandal; Niyaz Ahmed; Dorairajan Balasubramanian; Seyed E Hasnain; Hampapathalu A Nagarajaram
Journal:  Biophys J       Date:  2006-09-08       Impact factor: 4.033

5.  Induction patterns of new CYP1 genes in environmentally exposed rainbow trout.

Authors:  Maria E Jönsson; Kai Gao; Jan A Olsson; Jared V Goldstone; Ingvar Brandt
Journal:  Aquat Toxicol       Date:  2010-03-11       Impact factor: 4.964

6.  New CYP1 genes in the frog Xenopus (Silurana) tropicalis: induction patterns and effects of AHR agonists during development.

Authors:  Maria E Jönsson; Cecilia Berg; Jared V Goldstone; John J Stegeman
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-18       Impact factor: 4.219

7.  Basal and 3-methylcholanthrene-induced expression of cytochrome P450 1A, 1B and 1C genes in the Brazilian guppy, Poecilia vivipara.

Authors:  Tarquin Dorrington; Juliano Zanette; Flávia L Zacchi; John J Stegeman; Afonso C D Bainy
Journal:  Aquat Toxicol       Date:  2012-08-14       Impact factor: 4.964

8.  Primary Congenital Glaucoma and the Involvement of CYP1B1.

Authors:  Kiranpreet Kaur; Anil K Mandal; Subhabrata Chakrabarti
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

9.  Cytochrome p450 1 genes in birds: evolutionary relationships and transcription profiles in chicken and Japanese quail embryos.

Authors:  Maria E Jönsson; Bruce R Woodin; John J Stegeman; Björn Brunström
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

10.  Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.

Authors:  Fritz F Parl; Kathleen M Egan; Chun Li; Philip S Crooke
Journal:  Cancer Inform       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.